Jundishapur Journal of Microbiology

Published by: Kowsar

Comparison of Biological and Immunological Characterization of Lipopolysaccharides From Brucella abortus RB51 and S19

Zahra Kianmehr 1 , Sussan Kaboudanian Ardestani 1 , * , Hoorieh Soleimanjahi 2 , Fatemeh Fotouhi 3 , Saeed Alamian 4 and Shahin Ahmadian 5
Authors Information
1 Immunology Lab, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, IR Iran
2 Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
3 Department of Influenza, Pasteur Institute of Iran, Tehran, IR Iran
4 Department of Brucellosis, Razi Vaccine and Serum Research Institute, Karaj, IR Iran
5 Department of Biochemistry, Institute of Biochemistry and Biophysics, University of Tehran, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: November 01, 2015, 8 (11); e24853
  • Published Online: November 7, 2015
  • Article Type: Research Article
  • Received: October 30, 2014
  • Revised: December 3, 2014
  • Accepted: December 9, 2014
  • DOI: 10.5812/jjm.24853

To Cite: Kianmehr Z, Kaboudanian Ardestani S, Soleimanjahi H, Fotouhi F, Alamian S, et al. Comparison of Biological and Immunological Characterization of Lipopolysaccharides From Brucella abortus RB51 and S19, Jundishapur J Microbiol. 2015 ; 8(11):e24853. doi: 10.5812/jjm.24853.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Corbel MJWJB-M. Bergey's Manual of Systematic Bacteriology. 1984;
  • 2. Cardoso PG, Macedo GC, Azevedo V, Oliveira SC. Brucella spp noncanonical LPS: structure, biosynthesis, and interaction with host immune system. Microb Cell Fact. 2006; 5: 13[DOI][PubMed]
  • 3. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, et al. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. 1999; 162(7): 3749-52[PubMed]
  • 4. Baldridge JR, McGowan P, Evans JT, Cluff C, Mossman S, Johnson D, et al. Taking a Toll on human disease: Toll-like receptor 4 agonists as vaccine adjuvants and monotherapeutic agents. Expert Opin Biol Ther. 2004; 4(7): 1129-38[DOI][PubMed]
  • 5. Forestier C, Moreno E, Meresse S, Phalipon A, Olive D, Sansonetti P, et al. Interaction of Brucella abortus lipopolysaccharide with major histocompatibility complex class II molecules in B lymphocytes. Infect Immun. 1999; 67(8): 4048-54[PubMed]
  • 6. Berman DT, Kurtz RS. Relationship of biological activities to structures of Brucella abortus endotoxin and LPS. Ann Inst Pasteur Microbiol. 1987; 138(1): 98-101[PubMed]
  • 7. Cherwonogrodszky JWG, Dubray E, Moreno MH. Animal brucellosis. 1990; : 19-64
  • 8. Goldstein J, Hoffman T, Frasch C, Lizzio EF, Beining PR, Hochstein D, et al. Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines. Infect Immun. 1992; 60(4): 1385-9[PubMed]
  • 9. Keleti G, Feingold DS, Youngner JS. Interferon induction in mice by lipopolysaccharide from Brucella abortus. Infect Immun. 1974; 10(1): 282-3[PubMed]
  • 10. McQuiston JR, Vemulapalli R, Inzana TJ, Schurig GG, Sriranganathan N, Fritzinger D, et al. Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence. Infect Immun. 1999; 67(8): 3830-5[PubMed]
  • 11. Bundle DR, Cherwonogrodzky JW, Gidney MA, Meikle PJ, Perry MB, Peters T. Definition of Brucella A and M epitopes by monoclonal typing reagents and synthetic oligosaccharides. Infect Immun. 1989; 57(9): 2829-36[PubMed]
  • 12. Freer E, Rojas N, Weintraub A, Lindberg AA, Moreno E. Heterogeneity of Brucella abortus lipopolysaccharides. Res Microbiol. 1995; 146(7): 569-78[PubMed]
  • 13. Diaz R, Jones LM, Leong D, Wilson JB. Surface antigens of smooth brucellae. J Bacteriol. 1968; 96(4): 893-901[PubMed]
  • 14. Nicoletti P. Animal brucellosis. 1990; : 283-300
  • 15. MacMillan A. Animal brucellosis. 1990; 53-97
  • 16. Allen CA, Adams LG, Ficht TA. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival. Infect Immun. 1998; 66(3): 1008-16[PubMed]
  • 17. Schurig GG, Roop RM, Bagchi T, Boyle S, Buhrman D, Sriranganathan N. Biological properties of RB51; a stable rough strain of Brucella abortus. Vet Microbiol. 1991; 28(2): 171-88[PubMed]
  • 18. Winter AJ, Schurig GG, Boyle SM, Sriranganathan N, Bevins JS, Enright FM, et al. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4. Am J Vet Res. 1996; 57(5): 677-83[PubMed]
  • 19. Leong D, Diaz R, Milner K, Rudbach J, Wilson JB. Some structural and biological properties of Brucella endotoxin. Infect Immun. 1970; 1(2): 174-82[PubMed]
  • 20. Moreno E, Pitt MW, Jones LM, Schurig GG, Berman DT. Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus. J Bacteriol. 1979; 138(2): 361-9[PubMed]
  • 21. Kurtz RS, Berman DT. Influence of endotoxin-protein in immunoglobulin G isotype responses of mice to Brucella abortus lipopolysaccharide. Infect Immun. 1986; 54(3): 728-34[PubMed]
  • 22. Sharifat SA, Siadat SD, Norouzian D, Ahmadi H, Nejati M, Tabaraie B, et al. Optimization of Brucella abortus S99 lipopolysaccharide extraction by phenol and butanol methods. Rese J Biol Sci. 2008; 3(6): 576-80
  • 23. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, Ward DC, et al. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun. 2001; 69(3): 1477-82[DOI][PubMed]
  • 24. Moreno E, Jones LM, Berman DT. Immunochemical characterization of rough Brucella lipopolysaccharides. Infect Immun. 1984; 43(3): 779-82[PubMed]
  • 25. Karkhanis YD, Zeltner JY, Jackson JJ, Carlo DJ. A new and improved microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of Gram-negative bacteria. Anal Biochem. 1978; 85(2): 595-601[PubMed]
  • 26. Ames BN, Elizabeth F, Neufeld VG. Methods Enzymol. 1966; : 115-8
  • 27. Raff RA, Wheat RW. Carbohydrate composition of the phenol-soluble lipopolysaccharides of Citrobacter freundii. J Bacteriol. 1968; 95(6): 2035-43[PubMed]
  • 28. Tsai CM, Frasch CE. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem. 1982; 119(1): 115-9[PubMed]
  • 29. Ouchterlony O, Nilsson LA. Handbook of experimental immunology. 1973;
  • 30. Fairbanks G, Steck TL, Wallach DF. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry. 1971; 10(13): 2606-17[PubMed]
  • 31. Lapaque N, Moriyon I, Moreno E, Gorvel JP. Brucella lipopolysaccharide acts as a virulence factor. Curr Opin Microbiol. 2005; 8(1): 60-6[DOI][PubMed]
  • 32. Huang L, Krieg AM, Eller N, Scott DE. Induction and regulation of Th1-inducing cytokines by bacterial DNA, lipopolysaccharide, and heat-inactivated bacteria. Infect Immun. 1999; 67(12): 6257-63[PubMed]
  • 33. Billiau A, Schonne E, Eyckmans L, De Somer P. Interferon Induction and Resistance to Virus Infection in Mice Infected with Brucella abortus. Infect Immun. 1970; 2(6): 698-704[PubMed]
  • 34. Somer P, Clercq E, Cocito C, Billiau A. The Interferon Inducer from Brucella. Annals of the N Y Academy of Sci. 1970; 173(1 Second Confer): 274-81[DOI]
  • 35. Youngner JS, Feingold DS, Chen JK. Involvement of a chemical moiety of bacterial lipopolysaccharide in production of interferon in animals. J Infect Dis. 1973; 128-31[PubMed]
  • 36. Kariminia A, Kavoossy G, Khatami S, Zowghi E, Ardestani SK. Study of interleukin-10 and interleukin-12 productions in response to lipopolysaccharides extracted from two different Brucella strains. Comp Immunol Microbiol Infect Dis. 2002; 25(2): 85-93[PubMed]
  • 37. Jarvis BW, Harris TH, Qureshi N, Splitter GA. Rough lipopolysaccharide from Brucella abortus and Escherichia coli differentially activates the same mitogen-activated protein kinase signaling pathways for tumor necrosis factor alpha in RAW 264.7 macrophage-like cells. Infect Immun. 2002; 70(12): 7165-8[PubMed]
  • 38. Vella AT, McCormack JE, Linsley PS, Kappler JW, Marrack P. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity. 1995; 2(3): 261-70[PubMed]
  • 39. Ritter U, Meissner A, Ott J, Korner H. Analysis of the maturation process of dendritic cells deficient for TNF and lymphotoxin-alpha reveals an essential role for TNF. J Leukoc Biol. 2003; 74(2): 216-22[PubMed]
  • 40. Johnson AG, Gaines S, Landy M. Studies on the O antigen of Salmonella typhosa. V. Enhancement of antibody response to protein antigens by the purified lipopolysaccharide. J Exp Med. 1956; 103(2): 225-46[PubMed]
  • 41. Jamalan M, Ardestani SK, Zeinali M, Mosaveri N, Mohammad Taheri M. Effectiveness of Brucella abortus lipopolysaccharide as an adjuvant for tuberculin PPD. Biologicals. 2011; 39(1): 23-8[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments